We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$14.7B
AUM Growth
+$1.51B
Cap. Flow
+$91.2M
Cap. Flow %
0.62%
Top 10 Hldgs %
18.69%
Holding
1,131
New
82
Increased
379
Reduced
530
Closed
67

Top Sells

Rank Stock Value
1
MKL icon
Markel Group
MKL
+$82.1M
2
TTWO icon
Take-Two Interactive
TTWO
+$59.4M
3
ADBE icon
Adobe
ADBE
+$50.3M
4
WSO icon
Watsco Inc
WSO
+$23.8M
5
AVGO icon
Broadcom
AVGO
+$20.4M

Sector Composition

Rank Sector Weight
1 Financials 17.67%
2 Technology 14.1%
3 Healthcare 11.33%
4 Consumer Discretionary 9.48%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
126
Coca-Cola
KO
$377B
$25.3M 0.17%
429,535
-34,136
-7% -$1.94M
SEB icon
127
Seaboard Corp
SEB
$4.23B
$25.1M 0.17%
7,035
+191
+3% +$679K
XLK icon
128
State Street Technology Select Sector SPDR ETF
XLK
$115B
$25M 0.17%
259,792
+13,452
+5% +$1.2M
EZM icon
129
WisdomTree US MidCap Fund
EZM
$940M
$24.5M 0.17%
427,655
+40,393
+10% +$2.09M
XLV icon
130
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$24.5M 0.17%
179,780
+15,507
+9% +$2.02M
CLH icon
131
Clean Harbors
CLH
$16.5B
$24M 0.16%
+136,918
New +$22.5M
LILAK icon
132
Liberty Latin America Class C
LILAK
$1.63B
$23.9M 0.16%
3,595,664
+164,672
+5% +$1.07M
CRC icon
133
California Resources
CRC
$4.67B
$23.1M 0.16%
420,946
+270,508
+180% +$14.2M
SBIO icon
134
ALPS Medical Breakthroughs ETF
SBIO
$201M
$22.7M 0.15%
687,786
-125
-0% -$3.36K
CVS icon
135
CVS Health
CVS
$133B
$22.5M 0.15%
284,616
-26,651
-9% -$1.9M
ALB icon
136
Albemarle
ALB
$13.9B
$22M 0.15%
152,561
-16,866
-10% -$2.32M
PG icon
137
Procter & Gamble
PG
$336B
$21.9M 0.15%
149,382
+3,573
+2% +$529K
DUK icon
138
Duke Energy
DUK
$97.8B
$21.1M 0.14%
217,738
+3,229
+2% +$294K
VYM icon
139
Vanguard High Dividend Yield ETF
VYM
$80.9B
$20.8M 0.14%
186,169
+10,475
+6% +$1.1M
CSCO icon
140
Cisco
CSCO
$457B
$20.7M 0.14%
409,613
-7,117
-2% -$364K
VWO icon
141
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$20.1M 0.14%
487,900
+13,948
+3% +$553K
MRSH
142
Marsh
MRSH
$90.5B
$19.7M 0.13%
104,111
-25,537
-20% -$4.93M
DHIL
143
DELISTED
Diamond Hill
DHIL
$19.1M 0.13%
115,402
DV icon
144
DoubleVerify
DV
$1.73B
$18.6M 0.13%
505,944
+57,436
+13% +$1.79M
SHEN icon
145
Shenandoah Telecom
SHEN
$664M
$18.5M 0.13%
861,381
-13,662
-2% -$306K
D icon
146
Dominion Energy
D
$60.8B
$18.2M 0.12%
387,758
+46,959
+14% +$2.1M
LLY icon
147
Eli Lilly
LLY
$1.02T
$18.1M 0.12%
31,036
-466
-1% -$272K
TREX icon
148
Trex
TREX
$4.51B
$18M 0.12%
217,269
+50,367
+30% +$3.34M
SCHW
149
Charles Schwab
SCHW
$183B
$17.4M 0.12%
252,675
+24,389
+11% +$1.41M
TFC icon
150
Truist Financial
TFC
$63.3B
$17.1M 0.12%
462,208
+104,986
+29% +$3.3M

Similar funds

Davenport & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Davenport & Co held 1,131 positions worth $14.7B, up 11% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Davenport & Co's Q4 2023 filing shows 82 new, 379 increased, 530 reduced and 67 closed positions. Its largest new stake was Clean Harbors: 136,918 shares worth $24M. The largest sale was Markel Group, an estimated $82.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q4 2023 buy was Clean Harbors: 136,918 shares worth $24M.
  • Davenport & Co added most to Kinsale Capital Group in Q4 2023, an estimated $73.5M increase.
  • Davenport & Co's biggest Q4 2023 reduction was Markel Group, cutting an estimated $82.1M.
  • Davenport & Co fully exited First Trust Nasdaq Food & Beverage ETF in Q4 2023, selling an estimated $1.29M.
  • Davenport & Co's ten largest holdings make up 19% of its $14.7B portfolio in Q4 2023.
  • Davenport & Co opened 82 new positions and closed 67 in Q4 2023.
  • Davenport & Co's portfolio value rose 11% quarter-over-quarter to $14.7B.

Based on Davenport & Co's 13F filing for Q4 2023, filed 23 Jan 2024.